Maypharm Co., Ltd.
The delivery date is confirmed based on stock and suitable shipping.
For delivery within the Netherlands. Orders after 16:00 are processed on the next working day. We confirm delivery dates separately for other countries.Need help with your first order? Use the product enquiry below. Include the number of packs and delivery country. VAT and available shipping costs are shown before payment.
Review the product information first. Create and activate your professional account to see business pricing, volume tiers and current availability. You will then return to this product.
VAIM: 170 mg PDLLA en 30 mg HA per vial. Fabrikantdocumentatie.
Lenisna is a VAIM product within the family of PDLLA and hyaluronic acid products. It is a biostimulator and not an ordinary hyaluronic acid gel filler. The manufacturer distinguishes Lenisna from Juvelook 50 mg on the basis of composition and product positioning; the variants are not interchangeable.
Check the manufacturer or distributor details and the exact product identity on the packaging and accompanying documents of the supplied version.
In its brochure, VAIM positions Lenisna for subcutaneous volume improvement and mentions facial laxity, volume loss, nasolabial folds and deep atrophic acne scars, among others. This is manufacturer-oriented product information and not an individual treatment indication. The formal indications and conditions follow from the current local instructions for use belonging to the supplied variant; a licensed professional assesses whether that information applies.
The VAIM brochure lists Lenisna as the 200 mg version with 170 mg PDLLA and 30 mg HA, whereas Juvelook 50 mg contains 42.5 mg PDLLA and 7.5 mg HA. The brochure also positions the products for different tissue layers and goals. Therefore do not compare milligrams, areas of use or product information as though they were the same version.
On receipt, check the name, 200 mg sales unit, packaging and manufacturer details against your order and the official product documentation. The supplied batch can be traced through its batch/lot number. Also note the expiry date and keep the batch details with your delivery documentation. Contact Cosmoface if details are missing or do not match.
The VAIM brochure lists 170 mg PDLLA and 30 mg hyaluronic acid for the 200 mg version. Check this on the documentation of the exact pack received.
No. The VAIM brochure describes different quantities and product positioning: Lenisna 200 mg and Juvelook 50 mg are separate variants.
In the product brochure, VAIM mentions facial laxity, volume loss, nasolabial folds and deep atrophic acne scars, among others. Consult the local instructions for use of the supplied version for formal indications.
Lenisna is manufactured by VAIM; distributor and brand details on packaging and delivery documents can vary by market. Compare the packaging and delivery documents of the supplied batch.
This text is for professional product orientation. The current instructions for use of the exact pack supplied remain decisive.
Check the product version, packaging, expiry date and batch/lot data on receipt.
Lenisna PDLLA + HA 1 x 200 mg for your clinic or practice? Review the product information, version and item code above. After activating your business account, log in to view the current price and availability and compose your order.
Read the background information and compare product names and packaging before preparing your business enquiry.
All product information and brands →Ask about quantities, delivery or regular orders of Lenisna PDLLA + HA 1 x 200 mg. Your product is prefilled in the contact form.